Skip to main content

Advertisement

Log in

The Cost of Complications Following Major Resection of Malignant Neoplasia

  • Original Article
  • Published:
Journal of Gastrointestinal Surgery Aims and scope

Abstract

Background

Rising healthcare costs have led to increased focus on the need to achieve a higher “value of care.” As value-maximization efforts expand to include more complex surgical patients, evidence to support meaningful implementation of complication-based initiatives is lacking. The objective of this study was to compare incremental costs of complications following major gastrointestinal (GI) resections for organ-specific malignant neoplasia using nationally representative data.

Methods

National (Nationwide) Inpatient Sample data, 2001–2014, were queried for adult (≥ 18 years) patients undergoing major resections for malignant neoplasia. Based on system-based complications considered relevant to the long-term treatment of GI disease, stratified differences in risk-adjusted incremental hospital costs and complication probabilities were compared. Differences in surgical outcomes and costs over time were also assessed.

Results

A total of 293,967 patients were included, weighted to represent 1,408,117 patients nationwide. One fourth (26.1%; 95% CI, 25.7–26.4%) experienced ≥ 1 pre-discharge complication (range, 45.3% esophagectomy to 24.0% rectal resection). Resultant annual risk-adjusted incremental hospital costs totaled $540 million nationwide (19.5% of the overall cost of care and an average of $20,900 per patient). Costs varied substantially with both cancer/resection type and complication group, ranging from $76.7 million for colectomies with infectious complications to $0.2 million for rectal resections with urinary complications. For each resection type, infectious ($154.7 million), GI ($85.5 million), and pulmonary ($77.9 million) complications were among the most significant drivers of increased hospital cost.

Conclusions

Quantifying and comparing the impact of complications on an indication-specific level in more complex patients offers an important step toward allowing providers/payers to meaningfully prioritize the design of novel and adaptation of existing value-maximization approaches.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Health Expenditures Data for the U.S. May 2017, Centers for Disease Control and Prevention, National Center for Health Statistics. Available at: https://www.cdc.gov/nchs/fastats/health-expenditures.htm. Accessed January 1, 2018.

  2. National Health Expenditure Projections 2015–2025 Centers for Medicare and Medicaid Services (CMS). Available at: https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/proj2015.pdf. Accessed January 1, 2018.

  3. GDP per capita growth (annual %): United States 2017, The World Bank Group. Available at: http://data.worldbank.org/indicator/NY.GDP.PCAP.KD.ZG?locations=US. Accessed January 1, 2018.

  4. Porter ME. What is value in health care? N Engl J Med 2010; 363(26):2477–81.

    Article  CAS  Google Scholar 

  5. Birkmeyer JD, Gust C, Baser O, et al. Medicare payments for common inpatient procedures: implications for episode-based payment bundling. Health Serv Res 2010; 45(6 Pt 1):1783–95.

    Article  Google Scholar 

  6. Dimick JB, Weeks WB, Karia RJ, et al. Who pays for poor surgical quality? Building a business case for quality improvement. J Am Coll Surg 2006; 202(6):933–7.

    Article  Google Scholar 

  7. Vonlanthen R, Slankamenac K, Breitenstein S, et al. The impact of complications on costs of major surgical procedures: A cost analysis of 1200 patients. Ann Surg 2011; 254(6):907–13.

    Article  Google Scholar 

  8. Haider AH, Gupta S, Zogg CK, et al. Beyond incidence: Costs of complications in trauma and what it means for those who pay. Surgery 2015; 158(1):96–103.

    Article  Google Scholar 

  9. Mehrotra A, Hussey P. Including physicians in bundled hospital care payments: Time to revisit an old idea? Jama 2015; 313(19):1907–8.

    Article  Google Scholar 

  10. Zogg CK, Najjar P, Diaz AJ, et al. Rethinking priorities: Cost of complications after elective colectomy. Ann Surg 2016; 264(2):312–22.

    Article  Google Scholar 

  11. Shih T, Nicholas LH, Thumma JR, et al. Does pay-for-performance improve surgical outcomes? An evaluation of phase 2 of the Premier Hospital Quality Incentive Demonstration. Ann Surg 2014; 259(4):677–81.

    Article  Google Scholar 

  12. Epstein AM, Joynt KE, Jha AK, et al. Access to coronary artery bypass graft surgery under pay for performance: Evidence from the premier hospital quality incentive demonstration. Circ Cardiovasc Qual Outcomes 2014; 7(5):727–34.

    Article  Google Scholar 

  13. Value Based Programs [CMS.gov Centers for Medicare & Medicaid Services web site]. March 24, 2017. Available at: https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-Programs/Value-Based-Programs.html. Accessed January 1, 2018.

  14. Ryan AM, Krinsky S, Maurer KA, et al. Changes in hospital quality associated with hospital value-based purchasing. N Engl J Med 2017; 376(24):2358–66.

    Article  Google Scholar 

  15. Ibrahim AM, Nathan H, Thumma JR, et al. Impact of the Hospital Readmission Reduction Program on surgical readmissions among Medicare beneficiaries. Ann Surg 2017; 266(4):617–24.

    Article  Google Scholar 

  16. Shih T, Ryan AM, Gonzalez AA, et al. Medicare’s Hospital Readmissions Reduction Program in surgery may disporportionately affect minority-serving hospitals. Ann Surg 2015; 261(6):1027–31.

    Article  Google Scholar 

  17. Curtin BM, Russell RD, Odum SM. Bundled payments for care improvement: Boom or bust? J Arthroplasty 2017; 32(10):2931–4.

    Article  Google Scholar 

  18. Courtney PM, Ashley BS, Hume EL, et al. Are bundled payments a viable reimbursement model for revision of total joint arthroplasty? Clin Orthop Relat Res 2016; 474(12):2714–21.

    Article  Google Scholar 

  19. Gani F, Makary MA, Wick EC, et al. Bundled payments for surgical colectomy among Medicare enrollees: Potential savings vs the need for further reform. JAMA Surg 2016; 151(5):e160202.

    Article  Google Scholar 

  20. Hawken SR, Ryan AM, Miller DC. Surgery and Medicare Shared Savings Program accountable care organizations. JAMA Surg 2016; 151(1):5–6.

    Article  Google Scholar 

  21. Mehaffey JH, Hawkins RB, Mullen MG, et al. Access to quaternary care surgery: Implications for accountable care organizations. J Am Coll Surg 2017; 224(4):525–9.

    Article  Google Scholar 

  22. Resnick MJ, Graves AJ, Buntin MB, et al. Surgeon participation in early accountable care organizations. Ann Surg 2017.

  23. Mariotto AB, Yabroff KR, Shao Y, et al. Projections of the cost of cancer care in the United States: 2010-2020. J Natl Cancer Inst 2011; 103(2):117–28.

    Article  Google Scholar 

  24. Nathan H, Atoria CL, Bach PB, et al. Hospital volume, complications, and cost of cancer surgery in the elderly. J Clin Oncol 2015; 33(1):107–14.

    Article  Google Scholar 

  25. Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs [CMS.gov Centers for Medicare & Medicaid Services web site]. Available at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/Hospital-Outpatient-Regulations-and-Notices-Items/CMS-1678-P.html. Accessed January 1, 2018.

  26. 2015 Measure Information About the 30-Day All-Cause Hospital Readmission Measure, Calculated for the Value-based Payment Modifier Program [CMS.gov Centers for Medicare & Medicaid Services web site]. Available at: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/PhysicianFeedbackProgram/Downloads/2015-ACR-MIF.pdf. Accessed January 1, 2018.

  27. Gani F, Johnston FM, Nelson-Williams H, et al. Hospital volume and the costs associated with surgery for pancreatic cancer. J Gastrointest Surg 2017;21(9):1411–9.

    Article  Google Scholar 

  28. Ejaz A, Gonzalez AA, Gani F, et al. Effect of index hospitalization costs on readmission among patients undergoing major abdominal surgery. JAMA Surg 2016; 151(8):718–24.

    Article  Google Scholar 

  29. Cerullo M, Gani F, Chen SY, et al. Assessing the financial burden associated with treatment opioids for resectable pancreatic cancer. Ann Surg 2016.

  30. Selby LV, Gennarelli RL, Schnorr GC, et al. Association of hospital costs with complications following total gastrectomy for gastric adenocarcinoma. JAMA Surg 2017;152(10):953–8.

    Article  Google Scholar 

  31. Short MN, Ho V, Aloia TA. Impact of processes of care aimed at complication reduction on the cost of complex cancer surgery. J Surg Oncol 2015; 112(6):610–5.

    Article  Google Scholar 

  32. Fu SJ, Ho VP, Ginsberg J, et al. Complications, not minimally invasive surgical technique, are associated with increased cost after esophagectomy. Minim Invasive Surg 2016; 2016:7690632.

    PubMed  PubMed Central  Google Scholar 

  33. HCUP-US NIS Overview [HCUP Databases. Healthcare Cost and Utilization Project (HCUP) web site]. Available at: https://www.hcup-us.ahrq.gov/nisoverview.jsp. Accessed January 1, 2018.

  34. Scarborough JE, Schumacher J, Kent KC, et al. Associations of specific postoperative complications with outcomes after elective colon resection: A procedure-targeted approach toward surgical quality improvement. JAMA Surg 2017; 152(2):e164681.

    Article  Google Scholar 

  35. Minami CA, Dahlke AR, Barnard C, et al. Association between hospital characteristics and performance on the new Hospital-Acquired Condition Reduction Program’s surgical site infection measures. JAMA Surg 2016; 151(8):777–9.

    Article  Google Scholar 

  36. Bozic KJ, Grosso LM, Lin Z, et al. Variation in hospital-level risk-standardized complication rates following elective primary total hip and knee arthroplasty. J Bone Joint Surg Am 2014; 96(8):640–7.

    Article  Google Scholar 

  37. Rajaram R, Chung JW, Kinnier CV, et al. Hospital characteristics associated with penalities in the Centers for Medicare & Medicaid Services Hospital-Acquired Condition Reduction Program. JAMA 2015; 314(4):375–83.

    Article  CAS  Google Scholar 

  38. Pradarelli JC, Healy MA, Osborne NH, et al. Variation in Medicare expenditures for treating perioperative complications: The cost of rescue. JAMA Surg 2016; 151(12):e163340.

    Article  Google Scholar 

  39. Gani F, Cerullo M, Canner JK, et al. Defining payments associated with the treatment of colorectal cancer. J Surg Res 2017; 220:284–92.

    Article  Google Scholar 

Download references

Financial Disclosure

No funding specifically for this work was provided. Cheryl K Zogg, MSPH, MHS, is supported by NIH Medical Scientist Training Program Training Grant T32GM007205. She is the Primary Investigator of a grant from the Emergency Medical Foundation and American College of Emergency Physicians entitled “Understanding Emergency Medicine Providers’ Perceptions of the ACA in a Renewed Era of Healthcare Reform: National Survey and Qualitative Mixed-Methods Approach.” Adil H. Haider, MD, MPH, FACS, is the Primary Investigator of a contract (AD-1306-03980) with PCORI entitled “Patient-Centered Approaches to Collect Sexual Orientation/Gender Identity in the ED,” a Harvard Surgery Affinity Research Collaborative (ARC) Program Grant entitled “Mitigating Disparities Through Enhancing Surgeons’ Ability To Provide Culturally Relevant Care,” and a collaborative research grant from the Henry M. Jackson Foundation for the Advancement of Military Medicine in conjunction with the Uniformed Services University of the Health Sciences entitled “The Comparative Effectiveness and Provider Induced Demand Collaboration.” Haider is also a co-founder and equity-shareholder of the company Patient Doctor Technologies, Inc., which owns and operates the website www.doctella.com.

Author information

Authors and Affiliations

Authors

Contributions

Zogg, Murthy, Changoor, Zogg, Pawlik, and Haider made substantial contributions to the conception or design of the work; Zogg, Ottesen, and Changoor participated in the acquisition and analysis of the data; Zogg, Ottesen, Kebaish, Galivanche, Murthy, Changoor, Zogg, Pawlik, and Haider contributed toward the interpretation of data for the work; Zogg, Ottesen, Kebaish, and Galivanche drafted the manuscript; and Murthy, Changoor, Zogg, Pawlik, and Haider critically revised the manuscript for intellectual content. All authors provided final approval of the version to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Corresponding author

Correspondence to Cheryl K. Zogg.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

ESM 1

(PDF 79 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zogg, C.K., Ottesen, T.D., Kebaish, K.J. et al. The Cost of Complications Following Major Resection of Malignant Neoplasia. J Gastrointest Surg 22, 1976–1986 (2018). https://doi.org/10.1007/s11605-018-3850-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11605-018-3850-6

Keywords

Navigation